Pharma-Biotech Companies

Pharma-Biotech Companies overview

PGDx offers a suite of cancer genome analyses services to identify alterations in any tumor of interest. Our services sensitively and specifically identify genomic variants which can be linked to the underlying biology of cancer.

table
Sample typesTissueTissueLiquid biopsyLiquid biopsy
Analysis
Characteristics
CancerXOME™CancerSELECT™ 125PlasmaSELECT™ RMetDETECT™
Regions Analyzed>20,000 Genes125 Genes64 GenesMET Region
Sample Prep &
NGS Sequencing
Sequence Mapping
Somatic Mutation
Analysis
N/A
Copy Number
Analysis
Coming soon
Structural Alteration
Analysis
N/A
Germline Variant
Analysis
N/AN/A
Pathway &
Functional Analysis
N/AN/A
Integrated Project
Analysis

* Germline variant analysis is optional for these approaches when matched normal is provided